| __timestamp | AstraZeneca PLC | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5842000000 | 79838000 |
| Thursday, January 1, 2015 | 4646000000 | 121816000 |
| Friday, January 1, 2016 | 4126000000 | 117633000 |
| Sunday, January 1, 2017 | 4318000000 | 4577000 |
| Monday, January 1, 2018 | 4936000000 | 12670000 |
| Tuesday, January 1, 2019 | 4921000000 | 12135000 |
| Wednesday, January 1, 2020 | 5299000000 | 18942000 |
| Friday, January 1, 2021 | 12437000000 | 32328000 |
| Saturday, January 1, 2022 | 12391000000 | 44678000 |
| Sunday, January 1, 2023 | 8040000000 | 65486000 |
| Monday, January 1, 2024 | 10207000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. From 2014 to 2023, AstraZeneca PLC and PTC Therapeutics, Inc. have shown contrasting trends in their cost of revenue. AstraZeneca's cost of revenue surged by approximately 38% from 2014 to 2023, peaking in 2021 and 2022 with a staggering 12.4 billion. This reflects their aggressive expansion and investment in R&D. In contrast, PTC Therapeutics, Inc. experienced a more volatile journey, with costs fluctuating significantly, peaking in 2015 at 121.8 million, and then stabilizing around 65.5 million by 2023. This disparity highlights AstraZeneca's robust market position compared to PTC's strategic challenges. As the industry braces for future innovations, these financial insights offer a glimpse into the strategic maneuvers of these pharmaceutical giants.
AstraZeneca PLC vs Vertex Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
AstraZeneca PLC vs Teva Pharmaceutical Industries Limited: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: AstraZeneca PLC vs Halozyme Therapeutics, Inc.
Cost of Revenue: Key Insights for Intra-Cellular Therapies, Inc. and PTC Therapeutics, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc.'s Expenses
Jazz Pharmaceuticals plc vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: PTC Therapeutics, Inc. vs Bausch Health Companies Inc.
Analyzing Cost of Revenue: PTC Therapeutics, Inc. and Supernus Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for PTC Therapeutics, Inc. and Mesoblast Limited
Comparing Cost of Revenue Efficiency: PTC Therapeutics, Inc. vs Geron Corporation
PTC Therapeutics, Inc. vs Xencor, Inc.: Efficiency in Cost of Revenue Explored
PTC Therapeutics, Inc. vs Evotec SE: Efficiency in Cost of Revenue Explored